Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Ophthalmology Contract Research Organization (CRO) Market

Ophthalmology Contract Research Organization (CRO) Market Size

  • Report ID: GMI6617
  • Published Date: Sep 2023
  • Report Format: PDF

Ophthalmology Contract Research Organization (CRO) Market Size

Ophthalmology Contract Research Organization (CRO) Market accounted for USD 2.2 billion in 2022 and is anticipated to grow with a CAGR of 7.3% over the forecast period, to reach an estimated value of USD 4.4 billion by 2032.

 

Increasing prevalence of eye diseases coupled with rising demand for ophthalmic treatment are the major factors driving the industry by 2032. Outsourcing enables companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, reducing the time and costs associated with in-house development of ophthalmic drug, devices, and diagnostic solutions in vision care. Furthermore, increasing number of clinical trials being conducted worldwide and growing emphasis of pharma companies on R&D activities for development of novel products.

 

Ophthalmology contract research organizations are specialized service providers that offer comprehensive research and development support specifically focused on ophthalmology drugs, ophthalmic medical devices, and therapies. These services are outsourced by pharmaceutical, biopharmaceutical, and medical device company among others.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ophthalmology contract research organization (CRO) market size reached USD 2.2 billion in 2022 and will record USD 4.4 billion by 2032 due to the surging prevalence of eye diseases coupled with rising demand for ophthalmic treatment.

Ophthalmology contract research organization market size from pharmaceutical and biopharmaceutical companies exceeded USD 1.2 billion in 2022 owing to increasing investment for the development of novel ophthalmology therapies and drugs.

North America held 39.6% share of the ophthalmology contract research organization industry in 2022 on account of the rising R&D investments and high number of ophthalmology clinical trials in the region.

ICON plc Laboratory Corporation of America Holdings (Covance Inc.), Medpace, Inc., Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.), Syneos Health, and Worldwide Clinical Trials are some of the major industry players.

Ophthalmology Contract Research Organization (CRO) Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 16
  • Tables & Figures: 413
  • Countries covered: 16
  • Pages: 281
 Download Free Sample